FDA

Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
Kennedy's War On Food Dyes Could Be Coming To Your Breakfast Table
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

FDA Recent News

Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease.
Trump Says Robert Kennedy Jr. Can Run Wild On Health And Food: 'I'm Going To Let Him Go Wild On The Medicines'
Donald Trump plans to give Robert F. Kennedy Jr. major control over health, food, and medicine matters if re-elected, except for oil.
McDonald's Rivals Burger King, Yum Brands Remove Onions From Menus Amid Quarter-Pounder E.Coli Scare
FDA Launches Investigation Into McDonald's Supplier Taylor Farms Following E. Coli Outbreak
The Food and Drug Administration (FDA) has launched an investigation into Taylor Farms, a supplier for McDonald's Corporation (NYSE:MCD), after multiple people fell ill with E. coli linked to the restaurant chain's Quarter Pounder.
LIFD's 5x Potential: Is This Psychoactive Hemp Stock The Next Big Speculative Buy?
LIFD is expected to drive market share gains, according to a recent report from Zuanic & Associates, the stock could see a 5x rise by 2025.
FDA Rejection Of MDMA Could Fuel Black Market Demand, Warns CEO Of Women's Psychedelic Platform SetSet
The FDA rejected MDMA-assisted therapy for PTSD. SetSet's April Pride calls for harm-reduction education and regulatory change.
FDA Sets September Meeting To Discuss Psychedelic And Other Treatments For PTSD
FDA schedules public meeting to discuss potential psychedelic treatments for PTSD, inviting input from veterans, advocates and researchers
Regeneron Faces Setback With FDA Rejection Of Blood-Cancer Treatment
Regeneron Pharmaceuticals Inc. has received a setback as the Food and Drug Administration has declined its application for a blood cancer treatment.
Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
FDA rejects MDMA for PTSD, delaying access to life-saving treatment though some states are introducing psychedelic therapy programs.
FDA Backs Off Joint Study On Kratom And Psychedelics Amidst Public Criticism
The FDA withdraws its request to study kratom and psychedelics risks, following public criticism and accusations of bias against harm reduction strategies.
FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy
The FDA this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD.
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
The FDA is set to decide on MDMA therapy for PTSD, a move that could revolutionize treatment for veterans and others with severe trauma. Here's what's at stake
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
A new review finds MDMA therapy for PTSD promising but calls for more research before widespread adoption. Lawmakers urge FDA to reconsider its decision.
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety
FDA approves Incannex's Phase 2 trial for psilocybin-assisted psychotherapy in treating generalized anxiety disorder, following a successful review of the IND application.
Veterans Groups Urge FDA To Approve MDMA-Assisted Therapy For PTSD As August Decision Looms
Army boots near White House highlight veterans' suicide crisis, as advocates urge the FDA to approve MDMA-assisted therapy for PTSD.
FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban
FDA and FTC crack down on misleading hemp product marketing as Congress debates a nationwide ban on consumable hemp-derived cannabinoids.
Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
Bipartisan lawmakers and veterans push for FDA approval of MDMA therapy for PTSD, marking a milestone in mental health innovation.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Find out which five stocks saw an increase in reader interest during the trading week and how the stocks reacted.
FDA Committee 'Completely Lost Sight Of The Big Picture' Says Retired Lieutenant General Urging Approval On MDMA For PTSD
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program
Moderna's mRNA-370 has been selected for the FDA's START program to accelerate rare disease therapeutics, targeting a 2024 pivotal study.
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
A committee of advisors to the U.S. Food and Drug Administration (FDA) dealt a blow to the burgeoning field of psychedelic medicine by recommending against the approval of MDMA-assisted therapy as a treatment for PTSD.
MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy
MDMA nears FDA approval for PTSD treatment, sparking hope and controversy. Read now about its potential impact and the challenges ahead.
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
NIDA Director praises psychedelics, NCCIH highlights psilocybin's benefits and Atlanta explores adding psilocybin, ketamine to health plans.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved